Winton Group’s AnaptysBio ANAB Stock Holding History

Winton Group’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,487	Closed	-$312K	–	1010
2021 Q3	$312K	Buy	+11,487	New	+$292K	0.02%	1073
2018 Q4	–	Sell	-4,270	Closed	-$426K	–	857
2018 Q3	$426K	Sell	4,270 -5,507	-56%	-$457K	0.01%	691
2018 Q2	$695K	Sell	9,777 -4,131	-30%	-$347K	0.02%	528
2018 Q1	$1.45M	Buy	+13,908	New	+$1.57M	0.04%	398

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Winton Group's ANAB Position: Q4 2021 in Review

Winton Group sold out of AnaptysBio (ANAB) in Q4 2021, closing a stake of 11,487 shares — an estimated $312K sold.

Winton Group first reported a position in ANAB in Q1 2018 and held it in 4 quarters. The position peaked at $1.45M in Q1 2018. 136 funds tracked by Wall St. Rank hold ANAB as of Q4 2021.

Winton Group reported no remaining AnaptysBio position as of Q4 2021 after selling out during the quarter.
Winton Group sold 11,487 AnaptysBio shares in Q4 2021, an estimated $312K.
Winton Group first reported a position in AnaptysBio in Q1 2018 and held it in 4 quarters.
Winton Group's AnaptysBio position peaked at $1.45M in Q1 2018.
136 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.